This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Impact Biomedicines, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Curtis L Scribner: Innovator in Myeloproliferative Disorders Treatment
Introduction
Curtis L Scribner is a notable inventor based in Oakland, CA. He has made significant contributions to the field of medicine, particularly in the treatment of myeloproliferative disorders. His innovative approach has led to the development of methods that address thiamine deficiency, which is crucial for patients suffering from these conditions.
Latest Patents
Curtis L Scribner holds one patent titled "Methods of treating myeloproliferative disorders." This patent outlines effective methods for mitigating thiamine deficiency, showcasing his commitment to improving patient outcomes through scientific innovation.
Career Highlights
Scribner is associated with Impact Biomedicines, Inc., where he applies his expertise to advance medical research and treatment options. His work at the company reflects his dedication to addressing complex health issues through innovative solutions.
Collaborations
Curtis collaborates with talented professionals in his field, including Tymara Berry and John Hood. These partnerships enhance the research and development efforts at Impact Biomedicines, Inc., fostering a collaborative environment for innovation.
Conclusion
Curtis L Scribner's contributions to the treatment of myeloproliferative disorders highlight his role as an inventor dedicated to improving healthcare. His innovative methods and collaborations with colleagues underscore the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile